25 Jul 2022
CNS Pharmaceuticals Urges Shareholders to Vote in Favor of Proxy Proposals for the Upcoming Annual Meeting of Shareholders on July 27, 2022
Author: admintech | Filed under: Press ReleaseCompany reiterates support of proposals for the authorization to increase number of shares available for issuance by the Company and authorization for the Board to effect a reverse stock split at their discretion Video to shareholders from John Climaco, CEO of CNS Pharmaceuticals now…